A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PA / prostate-specific antigen

[Related PubMed/MEDLINE]
Total Number of Papers: 44
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PA  (>> Co-occurring Abbreviation)
Long Form:   prostate-specific antigen
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
1993 [Measurement of serum PA values by a newly developed enzyme immunoassay]. ---
1992 [Papillary adenocarcinoma of the prostate with good response to antiandrogen therapy and delayed radiotherapy: a case report]. ---
1992 [Prostatic specific antigen (PA) in mass screening for prostate cancer]. DRE, PAP, US
1991 Androgen receptors in endocrine-therapy-resistant human prostate cancer. AR, mAb
1991 Identification and androgen-regulated expression of two major human glandular kallikrein-1 (hGK-1) mRNA species. hGK-1
1991 Immunological comparison between prostate-specific antigen and gamma-seminoprotein. EIAs, gamma-Sm
1991 Multiple marker evaluation in prostatic cancer with prostatic acid phosphatase, gamma-seminoprotein and prostate-specific antigen. gamma-Sm, PAP
1991 The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. CAT
1991 [Clinical evaluation of serum basic fetoprotein for prostatic cancer--comparative study with PAP, gamma-Sm and PSA]. BFP, gamma-Sm, PAP
10  1991 [Relationship between reactivation and tumor markers in prostatic cancer]. gamma-Sm, PAP
11  1991 [Significance of prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in the urine. First report: the measurement of PAP, gamma-Sm and PA in the urine of patients with prostatic diseases]. gamma-Sm, PAP
12  1990 The role of prostatic specific antigen in monitoring prostatic cancer and its prognostic importance. BPH, PAP
13  1990 Value of prostate-specific antigen measurements in predicting lymph node involvement in prostatic cancer. ---
14  1990 [Clinical studies on tumor markers for monitoring prostate cancer patients; the evaluation of prostate-specific antigen and comparison with prostatic acid phosphatase and gamma-seminoprotein]. gamma-Sm, PAP, PD, PR
15  1990 [Measurements of prostatic acid phosphatase and prostate specific antigen by fully automated enzyme immunoassay system--its analytical and clinical evaluation]. gamma-Sm, PAP, ROC
16  1990 [The histological expression of prostate-specific antigen and its clinical significance in patients with prostate cancer]. BPH
17  1989 Multiple marker evaluation in prostatic cancer using prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase. gamma-Sm, PAP
18  1989 [Analysis of antigens recognized by anti-gamma-seminoprotein antibody and anti-prostate-specific antigen antibody by means of Ouchterlony method and western blotting method]. gamma-Sm
19  1989 [Clinical and endocrinological studies of the luteinizing hormone-releasing hormone analogue therapy in prostatic cancer patients]. DHT, LHRH, PAP
20  1989 [Clinical evaluation of serum prostatic specific antigen in prostatic cancer: simultaneous assays of prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase in 113 newly diagnosed patients with prostatic cancer]. BPH, gamma-Sm, PAP
21  1989 [Prostate-specific antigen (PA) and deoxyribonucleic acid (DNA) analysis in prostatic epithelial cells using flow cytometry]. BPH, DNA, FCM
22  1989 [The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers]. BPH, gamma-Sm, PAP
23  1988 [Comparison of 3 assay kits of prostate specific antigen in serum of prostatic cancer]. DPC, gamma-Sm, PAP
24  1988 [Prostate specific antigen in serum of the patients with prostatic cancer]. BPH, DPC, gamma-Sm, PAP
25  1988 [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer]. BPH, gamma-Sm, PAP
26  1988 [Purification of prostatic acid phosphatase and prostate specific antigen from human seminal plasma]. PAP, SDS-PAGE
27  1987 [Clinical evaluation of a prostate-specific antigen as a serum marker of prostatic cancer]. PAP
28  1987 [Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein]. gamma-Sm, PAP
29  1987 [Clinical study of tumor marker in prostatic carcinoma--clinical significance of the prostate specific antigen (PA)]. ---
30  1987 [Prostatic specific antigen in the serum in prostatic cancer]. ---
31  1987 [Significance of tumor markers in the treatment of urological malignancies]. AFP, gamma-Sm, HCH, PAP
32  1986 Histochemical study of R1881-binding protein, prostatic acid phosphatase, prostate-specific antigen, and r-seminoprotein in prostatic cancer. PAP
33  1986 Human prostate-specific antigen: structural and functional similarity with serine proteases. ---
34  1986 Prostate-specific antigen in prostate cancer. BPH, EIA
35  1986 Relative reliability of five serially measured markers for prognosis of progression in prostate cancer. ACP, BAP, PAP, TAP
36  1986 [Prostatic acid phosphatase and prostatic specific antigen measured by immunoenzyme assay]. PAP
37  1985 Immunohistochemical demonstration of prostate-specific antigen in metastases with the use of monoclonal antibody F5. ---
38  1985 Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 to D1 prostate cancer. ---
39  1984 Evaluation of commercial immunoperoxidase kits in diagnosis of prostate carcinoma. PAP, PSAP
40  1984 Measurement of prostate-specific antigen by radioimmunoassay. PAP
41  1984 [Purification and determination of human prostate specific antigen in the serum]. BPH, PAP, RIA, SDS-PAGE
42  1983 Evaluation of serum prostate-specific antigen in urologic cancers. BPH, EIA
43  1981 Use of human prostate-specific antigen in monitoring prostate cancer. ---
44  1980 Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. ---